Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-06-30 Purchase | 2020-07-02 4:16 pm | Akouos Inc. | AKUS | Novartis Bioventures Ltd NOVARTIS AG Former 10% Owner | 125,000 | $17 | $2,125,000 | 1,181,258 (Indirect) | View |
2020-06-18 Sale | 2020-06-22 4:52 pm | Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG Former 10% Owner | 1,002,212 | $8.2507 | $8,268,960 | 2,467,961 (Direct) | View |
2020-06-15 Sale | 2020-06-17 5:47 pm | Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 19,386 | $9.2134 | $178,610 | 3,470,173 (Direct) | View |
2020-06-10 Sale | 2020-06-12 6:33 pm | Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 17,232 | $9.332 | $160,810 | 3,489,559 (Direct) | View |
2020-06-05 Sale | 2020-06-09 8:02 pm | Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 21,311 | $9.568 | $203,904 | 3,506,791 (Direct) | View |
2020-06-02 Sale | 2020-06-04 5:36 pm | Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 14,965 | $9.6793 | $144,851 | 3,528,102 (Direct) | View |
2019-11-12 Purchase | 2019-11-12 4:15 pm | Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 250,000 | $12 | $3,000,000 | 3,543,067 (Indirect) | View |
2019-05-28 Purchase | 2019-05-30 9:27 pm | BICYCLE THERAPEUTICS plc | BCYC | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 168,630 | $14 | $2,360,820 | 1,769,641 (Direct) | View |
2019-04-25 Sale | 2019-04-29 5:23 pm | Aerpio Pharmaceuticals Inc. | ARPO | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 701,800 | $1.03 | $722,854 | 4,049,804 (Indirect) | View |
2019-04-22 Sale | 2019-04-24 7:03 pm | Aerpio Pharmaceuticals Inc. | ARPO | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 51,057 | $1.0217 | $52,163 | 4,751,604 (Indirect) | View |
2019-04-11 Sale | 2019-04-15 9:26 pm | Aerpio Pharmaceuticals Inc. | ARPO | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 117,140 | $1.0473 | $122,683 | 4,802,661 (Indirect) | View |
2019-04-08 Sale | 2019-04-10 6:26 pm | Aerpio Pharmaceuticals Inc. | ARPO | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 200,746 | $1.0673 | $214,247 | 4,919,801 (Indirect) | View |
2019-04-03 Sale | 2019-04-05 5:14 pm | Aerpio Pharmaceuticals Inc. | ARPO | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 130,594 | $0.98967 | $129,245 | 5,120,547 (Indirect) | View |
2019-03-29 Sale | 2019-04-02 8:23 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 127,150 | $1.8581 | $236,258 | 2,079,394 (Direct) | View |
2019-03-29 Sale | 2019-04-02 8:09 pm | Aerpio Pharmaceuticals Inc. | ARPO | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 231,763 | $0.94358 | $218,686 | 5,251,141 (Indirect) | View |
2019-03-26 Sale | 2019-03-28 5:16 pm | Aerpio Pharmaceuticals Inc. | ARPO | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 317,346 | $0.98721 | $313,286 | 5,482,904 (Indirect) | View |
2019-03-13 Sale | 2019-03-15 5:25 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 190,338 | $2.0566 | $391,445 | 2,206,544 (Direct) | View |
2018-08-20 Sale | 2018-08-22 4:34 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 20,388 | $2.3 | $46,892 | 2,396,882 (Direct) | View |
2018-08-20 Sale | 2018-08-22 4:07 pm | Aerpio Pharmaceuticals Inc. | ARPO | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 5,300 | $3.9 | $20,670 | 5,800,250 (Indirect) | View |
2018-08-16 Sale | 2018-08-20 5:12 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 17,508 | $2.1 | $36,767 | 2,417,270 (Direct) | View |
2018-08-14 Sale | 2018-08-16 4:18 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 5,935 | $2.2112 | $13,123 | 2,434,778 (Direct) | View |
2018-08-10 Sale | 2018-08-14 5:05 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 7,215 | $2.4223 | $17,477 | 2,440,713 (Direct) | View |
2018-08-08 Sale | 2018-08-10 4:29 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 1,235 | $2.7229 | $3,363 | 2,447,928 (Direct) | View |
2018-08-06 Sale | 2018-08-08 4:21 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 4,681 | $3.0014 | $14,050 | 2,449,163 (Direct) | View |
2018-08-02 Sale | 2018-08-06 4:22 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 4,702 | $3.33 | $15,658 | 2,453,844 (Direct) | View |
2018-07-31 Sale | 2018-08-02 4:33 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 12,681 | $3.1668 | $40,158 | 2,458,546 (Direct) | View |
2018-07-27 Sale | 2018-07-31 4:16 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 8,458 | $3.354 | $28,368 | 2,471,227 (Direct) | View |
2018-07-25 Sale | 2018-07-27 4:21 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 20,397 | $3.7583 | $76,658 | 2,479,685 (Direct) | View |
2018-07-23 Sale | 2018-07-25 4:35 pm | AILERON THERAPEUTICS INC | ALRN | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 31,300 | $4.2469 | $132,927 | 2,500,082 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-06-15 Ownership | 2022-06-27 4:38 pm | N/A N/A | PRECISION BIOSCIENCES INC | DTIL | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner | 0 | $0 | 12,407,440 (Direct) | View |
2020-08-11 Ownership | 2020-08-14 4:32 pm | N/A N/A | Cellular Biomedicine Group Inc. | CBMG | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner | 0 | $0 | 1,458,257 (Direct) | View |
2020-07-14 Conversion | 2020-07-16 4:53 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner | 13,275,476 | $0 | 5,908,089 (Direct) | View |
2020-07-09 Ownership | 2020-07-13 06:02 am | N/A N/A | Poseida Therapeutics Inc. | PSTX | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner | 0 | $0 | 5,908,089 (Direct) | View |
2020-06-30 Conversion | 2020-07-02 4:16 pm | N/A N/A | Akouos Inc. | AKUS | Novartis Bioventures Ltd NOVARTIS AG Former 10% Owner | 1,056,258 | $0 | 1,181,258 (Indirect) | View |
2020-06-25 Ownership | 2020-06-25 7:15 pm | N/A N/A | Akouos Inc. | AKUS | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 0 | $0 | 1,056,258 (Indirect) | View |
2020-06-18 Ownership | 2020-06-18 9:16 pm | N/A N/A | Forma Therapeutics Holdings Inc. | FMTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 0 | $0 | 2,991,705 (Indirect) | View |
2019-11-12 Conversion | 2019-11-12 4:15 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 19,944,676 | $0 | 3,543,067 (Indirect) | View |
2019-11-06 Ownership | 2019-11-06 5:23 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 0 | $0 | 3,293,066 (Indirect) | View |
2019-05-28 Conversion | 2019-05-30 9:27 pm | N/A N/A | BICYCLE THERAPEUTICS plc | BCYC | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 1,529,561 | $0 | 1,769,641 (Direct) | View |
2019-05-28 Exercise | 2019-05-30 9:27 pm | N/A N/A | BICYCLE THERAPEUTICS plc | BCYC | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 71,450 | $0 | 1,769,641 (Direct) | View |
2019-05-22 Ownership | 2019-05-22 9:43 pm | N/A N/A | BICYCLE THERAPEUTICS Ltd | BCYC | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 0 | $0 | 1,601,011 (Direct) | View |
2018-12-31 Ownership | 2019-02-14 4:02 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Novartis Institutes for BioMedical Research Inc. NOVARTIS AG 10% Owner | 75,222 | $0 | 4,427,517 (Direct) | View |
2018-09-12 Other | 2018-09-14 09:14 am | 2017-08-21 2022-08-21 | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 2,535,079 | $0 | 10,415,138 (Indirect) | View |